E. A. Kolosova

Antibodies to the Spike Protein Receptor-Binding Domain of SARS-CoV-2 at 4–13 Months after COVID-19

E. Volosnikova, S. Belenkaya, D. Shcherbakov, 2022, Journal of clinical medicine.

Are Hamsters a Suitable Model for Evaluating the Immunogenicity of RBD-Based Anti-COVID-19 Subunit Vaccines?

A. A. Sergeev, E. Volosnikova, L. Karpenko, 2022, Viruses.

Development of Search Strategy for Peptide Inhibitors of Immune Checkpoints

S. V. Podlesnykh, A. Chapoval, D. Shanshin, 2018, Russian Journal of Bioorganic Chemistry.